Search

everythinglearnresearchcommunity

for

Search:↓

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

The book is a useful guide for dermatologists studying for their board exam, with clinical images and features of skin diseases.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Low vitamin D levels are linked to Alopecia Areata.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

SVF-enhanced fat injections may effectively treat baldness by promoting hair growth.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

HPV does not cause aggressive cancer in RDEB patients.

Valproic acid helps hair follicle stem cells survive better in low oxygen and glucose conditions.

Birt–Hogg–Dubé Syndrome requires genetic testing for accurate diagnosis due to its similarities with tuberous sclerosis.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

Diabetic patients' stem cells make vascular grafts more prone to clots, but new methods may improve grafts.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

PRAME helps distinguish between benign and malignant skin cells in most cases.

AS-OCT is crucial for diagnosing VZV interstitial keratitis and avoiding unnecessary treatments.

NB-UVB phototherapy is an effective and safe treatment for vitiligo, especially on hands and feet, and can be improved with tacrolimus.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

A scalp blood vessel issue from hair transplant was successfully treated with a special liquid agent.